April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Proof of concept for AAV-mediated gene transfer in iPSc-derived retinal pigment epithelium
Author Affiliations & Notes
  • Vasiliki Kalatzis
    Inserm U1051, Institute for Neurosciences of Montpellier, Montpellier, France
  • Nicolas Cereso
    Inserm U1051, Institute for Neurosciences of Montpellier, Montpellier, France
  • Marie Pequignot
    Inserm U1051, Institute for Neurosciences of Montpellier, Montpellier, France
  • Lorenne Robert
    Inserm U1051, Institute for Neurosciences of Montpellier, Montpellier, France
  • Fabienne Becker
    Inserm U632, Institute for Research in Biotherapies, Montpellier, France
  • Valerie De Luca
    Inserm U1051, Institute for Neurosciences of Montpellier, Montpellier, France
  • Nicolas Nabholz
    Inserm U1051, Institute for Neurosciences of Montpellier, Montpellier, France
  • Valerie Rigau
    Department of Anatomy and Pathological Cytology, CHRU St Eloi, Montpellier, France
  • John De Vos
    Inserm U632, Institute for Research in Biotherapies, Montpellier, France
  • Christian P Hamel
    Inserm U1051, Institute for Neurosciences of Montpellier, Montpellier, France
    Centre of Reference for Genetic Sensory Diseases, CHRU Montpellier, Montpellier, France
  • Footnotes
    Commercial Relationships Vasiliki Kalatzis, None; Nicolas Cereso, None; Marie Pequignot, None; Lorenne Robert, None; Fabienne Becker, None; Valerie De Luca, None; Nicolas Nabholz, None; Valerie Rigau, None; John De Vos, None; Christian Hamel, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3301. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Vasiliki Kalatzis, Nicolas Cereso, Marie Pequignot, Lorenne Robert, Fabienne Becker, Valerie De Luca, Nicolas Nabholz, Valerie Rigau, John De Vos, Christian P Hamel; Proof of concept for AAV-mediated gene transfer in iPSc-derived retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3301.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Inherited retinal dystrophies (IRDs) are a large group of genetically and clinically heterogeneous diseases leading to progressive vision loss, for which a paucity of disease-mimicking animal models can render pre-clinical studies difficult. We sought to develop pertinent human cellular IRD models, beginning with choroideremia, caused by mutations in CHM encoding Rab escort protein 1 (REP1). Choroideremia represents 2% of IRDs and is characterised by night blindness in childhood leading to blindness by 50 y of age. Mouse and zebrafish REP1-deficient models are lethal.

Methods: To generate a pertinent human cellular model, we reprogrammed REP1-deficient fibroblasts from a CHM-/y patient into induced pluripotent stem cells (iPSc). We then differentiated these patient-specific iPSc into REP1-deficient retinal pigment epithelium (RPE).

Results: We demonstrated that the iPSc-derived RPE is a polarised monolayer with a classical morphology, expresses characteristic markers, is functional for fluid transport and phagocytosis, and mimics the biochemical phenotype of patients. We assayed a panel of AAV vector serotypes in this human RPE and identified the serotype with the highest transduction efficiency (up to 60% transduction). This high and unmatched transduction efficiency is likely due to the phagocytic capacity of the iPSc-derived RPE, and therefore this model mimics the scenario an AAV vector encounters in vivo in the subretinal space. Furthermore, we demonstrated that AAV-mediated CHM gene transfer normalises the biochemical phenotype.

Conclusions: We identify the superior AAV serotype in functional human RPE, and, for the first time, show the potential of patient iPSc-derived RPE to provide a proof-of-concept for gene replacement in the absence of an appropriate animal model. This data is particularly pertinent in light of ongoing gene transfer studies for choroideremia, in particular, and IRDs, in general.

Keywords: 538 gene transfer/gene therapy • 701 retinal pigment epithelium • 696 retinal degenerations: hereditary  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×